HDAC1, histone deacetylase 1
In 2023, the FDA placed approximately 1719 peptides on the Category 2 restricted list citing safety concerns: potential carcinogenicity, immunogenicity risk, organ toxicity, and a lack of clinical trial data in humans
Safety lens: Botanicals/7,8-DHF = gentler, dietary-supplement vibe (still debate)
Pozwala bada jednorodno materiau, odzysk peptydu z nonika, stabilno formulacji i zmienno midzy jednostkami
doi: 10.1371/journal.pbio.3001182 145 JeongS-M-GYoonT-J
Reported side effects are generally mild and include temporary gastrointestinal discomfort, headaches during initial use, occasional fatigue as the body adjusts, and rare nausea, especially when taken without food